Watson Pharmaceuticals and Mallinckrodt have reached a settlement concerning a painkiller for which the former had sought Food and Drug Administration approval.
Specialty pharmacy provider BioScrip has appointed David Froesel as EVP, CFO and treasurer, the company said Wednesday. Froesel will begin immediately, replacing Stan Rosembaum, who plans to leave the company before the year ends.